Data

The Prescription Drug Price Transparency Act requires prescription drug manufacturers to report on new prescription drugs with a price exceeding $670 (the Medicare Part D specialty drug cost threshold). 

View the new drug report information

The Prescription Drug Price Transparency Act requires prescription drug manufacturers to report on prescription drugs that experienced net yearly price increases of 10% or more and had a price of $100 or more for a one-month supply during the previous year.

View the price increase report information

Oregon’s Prescription Drug Price Transparency Program requires health insurance companies to report on prescription drugs in Oregon. Health insurance companies reported the 25 most prescribed drugs, the 25 most costly prescription drugs, and the 25 prescription drugs that caused the biggest increases in yearly health plan spending in 2018.

View insurer price drug reports